Lenalidomide (Revlimid) in Patients With Previously Treated Chronic Lymphocytic Leukemia.

Trial Profile

Lenalidomide (Revlimid) in Patients With Previously Treated Chronic Lymphocytic Leukemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Aug 2012

At a glance

  • Drugs Lenalidomide (Primary)
  • Indications Chronic lymphocytic leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Sep 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Aug 2009 Planned number of patients changed from 35 to 45 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top